SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Supriya Lifescience informs about outcome of postal ballot

24 Apr 2025 Evaluate
Supriya Lifescience has informed that as set out in the Notice of Postal Ballot, the following resolutions have been passed with the requisite majority on April 23, 2025 Appointment of  Ganapati Dadasaheb Yadav (DIN: 02235661) as Non-Executive Independent Director of the Company (Ordinary Resolution); Appointment of Sunil Subhash Bhagwat (DIN: 10178976) as Non-Executive Independent Director of the Company (Ordinary Resolution).

The above information is a part of company’s filings submitted to BSE.

Supriya Lifescience Share Price

967.40 14.95 (1.57%)
11-Jun-2026 11:07 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1791.20
Dr. Reddys Lab 1277.65
Cipla 1383.50
Zydus Lifesciences 1104.85
Lupin 2253.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×